These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2327756

  • 1. Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Leroy A, Fillastre JP, Humbert G.
    Antimicrob Agents Chemother; 1990 Jan; 34(1):17-20. PubMed ID: 2327756
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA, Schultz RW, Schentag JJ.
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2364-8. PubMed ID: 2088191
    [Abstract] [Full Text] [Related]

  • 3. Ofloxacin pharmacokinetics in renal failure.
    Fillastre JP, Leroy A, Humbert G.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):156-60. PubMed ID: 3471179
    [Abstract] [Full Text] [Related]

  • 4. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function.
    Nilsen OG, Saltvedt E, Walstad RA, Marstein S.
    Am J Med; 1992 Apr 06; 92(4A):38S-40S. PubMed ID: 1316068
    [Abstract] [Full Text] [Related]

  • 5. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
    Lebrec D, Gaudin C, Benhamou JP.
    Am J Med; 1992 Apr 06; 92(4A):41S-44S. PubMed ID: 1316069
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A, Humbert G, Fillastre JP.
    Antimicrob Agents Chemother; 1981 Jun 06; 19(6):965-71. PubMed ID: 6455967
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of rufloxacin in patients with impaired renal function.
    Perry G, Mant TG, Morrison PJ, Sacks S, Woodcook J, Wise R, Imbimbo BP.
    Antimicrob Agents Chemother; 1993 Apr 06; 37(4):637-41. PubMed ID: 8388194
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP, Leroy A, Moulin B, Dhib M, Borsa-Lebas F, Humbert G.
    J Antimicrob Chemother; 1990 Oct 06; 26 Suppl B():51-60. PubMed ID: 2124213
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
    Morrison PJ, Mant TG, Norman GT, Robinson J, Kunka RL.
    Antimicrob Agents Chemother; 1988 Oct 06; 32(10):1503-7. PubMed ID: 3214495
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and safety of single oral doses of lomefloxacin.
    Morse IS.
    Biopharm Drug Dispos; 1990 Oct 06; 11(6):543-51. PubMed ID: 2207304
    [Abstract] [Full Text] [Related]

  • 12. Temafloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Granneman GR, Braeckman R, Kraut J, Shupien S, Craft JC.
    Antimicrob Agents Chemother; 1991 Nov 06; 35(11):2345-51. PubMed ID: 1666497
    [Abstract] [Full Text] [Related]

  • 13. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM, Hoepelman AI, Smit JM, Sips PA, Rozenberg-Arska M, Glerum JH, Verhoef J.
    Antimicrob Agents Chemother; 1992 Nov 06; 36(11):2458-61. PubMed ID: 1336948
    [Abstract] [Full Text] [Related]

  • 14. [Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
    Kolendo SE, Vorob'ev PA, Dvoretskiĭ LI, Izotova GN, Miagkov AV, Shvyreva GS, Iakovlev SV.
    Antibiot Khimioter; 1995 Mar 06; 40(3):47-51. PubMed ID: 7575015
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
    Stone JW, Andrews JM, Ashby JP, Griggs D, Wise R.
    Antimicrob Agents Chemother; 1988 Oct 06; 32(10):1508-10. PubMed ID: 3190181
    [Abstract] [Full Text] [Related]

  • 16. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
    Wijnands GJ, Cornel JH, Martea M, Vree TB.
    Chest; 1990 Dec 06; 98(6):1440-4. PubMed ID: 2245687
    [Abstract] [Full Text] [Related]

  • 17. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
    Kavi J, Stone J, Andrews JM, Ashby JP, Wise R.
    Eur J Clin Microbiol Infect Dis; 1989 Feb 06; 8(2):168-70. PubMed ID: 2498102
    [Abstract] [Full Text] [Related]

  • 18. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T, Fujimura A, Shiga T, Sasaki M, Harada K, Tateishi T, Ohashi K, Ebihara A.
    Eur J Clin Pharmacol; 1994 Feb 06; 46(3):267-9. PubMed ID: 8070509
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A, Humbert G, Fillastre JP, Borsa F, Godin M.
    J Antimicrob Chemother; 1983 Jul 06; 12(1):47-58. PubMed ID: 6619046
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Fillastre JP, Montay G, Bruno R, Etienne I, Dhib M, Vivier N, Le Roux Y, Guimart C, Gay G, Schott D.
    Antimicrob Agents Chemother; 1994 Apr 06; 38(4):733-7. PubMed ID: 8031038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.